prednisone has been researched along with Abnormal Karyotype in 6 studies
Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
Abnormal Karyotype: A variation from the normal set of chromosomes characteristic of a species.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 3 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yamaguchi, K | 1 |
| Kubota, Y | 1 |
| Kishimori, C | 1 |
| Ohno, H | 1 |
| Kidoguchi, K | 1 |
| Kizuka-Sano, H | 1 |
| Nishioka, A | 1 |
| Katsuya, H | 1 |
| Ando, T | 1 |
| Kimura, S | 1 |
| Bravo-Perez, C | 1 |
| Pajares, I | 1 |
| Muiña, B | 1 |
| Escobar, H | 1 |
| Amigo, ML | 1 |
| Garcia-Malo, MD | 1 |
| Garcia, J | 1 |
| Rodriguez-Pinilla, SM | 1 |
| Piris, MA | 1 |
| Ortuño, FJ | 1 |
| Schieck, M | 1 |
| Lentes, J | 1 |
| Thomay, K | 1 |
| Hofmann, W | 1 |
| Behrens, YL | 1 |
| Hagedorn, M | 1 |
| Ebersold, J | 1 |
| Davenport, CF | 1 |
| Fazio, G | 1 |
| Möricke, A | 1 |
| Buchmann, S | 1 |
| Alten, J | 1 |
| Cario, G | 1 |
| Schrappe, M | 1 |
| Bergmann, AK | 1 |
| Stanulla, M | 1 |
| Steinemann, D | 1 |
| Schlegelberger, B | 1 |
| Cazzaniga, G | 1 |
| Göhring, G | 1 |
| Chen, Z | 1 |
| Hu, S | 1 |
| Sadrzadeh, H | 1 |
| Hasserjian, R | 1 |
| Fathi, AT | 1 |
| PEDERSEN, B | 1 |
| VIDEBAEK, A | 1 |
6 other studies available for prednisone and Abnormal Karyotype
| Article | Year |
|---|---|
Epstein-Barr virus-positive diffuse large B cell lymphoma, not otherwise specified, carrying a t(19;22)(q13;q11) translocation.
Topics: Abnormal Karyotype; Aged; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Chromosomes | 2020 |
Double hit B cell precursor leukemia/lymphoma in a patient with a prior diagnosis of follicular lymphoma: a diagnostic and therapeutic dilemma.
Topics: Abnormal Karyotype; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Asparaginase | 2020 |
Implementation of RNA sequencing and array CGH in the diagnostic workflow of the AIEOP-BFM ALL 2017 trial on acute lymphoblastic leukemia.
Topics: Abnormal Karyotype; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Comparative Genomi | 2020 |
MYC/BCL2 double-hit lymphoma/leukemia mimicking acute leukemia at initial presentation.
Topics: Abnormal Karyotype; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combin | 2016 |
Pure erythroid leukemia evolving from a therapy-related myelodysplastic syndrome secondary to treatment for chronic lymphocytic leukemia.
Topics: Abnormal Karyotype; Aged; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Cyclophosphami | 2013 |
SEVERAL CELL-LINES WITH ABNORMAL KARYOTYPES IN A PATIENT WITH CHRONIC MYELOGENOUS LEUKAEMIA.
Topics: Abnormal Karyotype; Blood Cell Count; Bone Marrow Examination; Busulfan; Chromosome Aberrations; Chr | 1964 |